14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
FMC vs SMG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, The Scotts Miracle-Gro Company (SMG) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). FMC carries a Unified Composite Score of 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin), whereas SMG carries 39.4/100 (SELL) at $62.79 (13.5x Forward P/E, 13.5% operating margin).
Composite vs. Pillar Nuance: While FMC currently prints a higher short-term Unified Composite Score (46.7/100 HOLD vs. SMG 39.4/100 SELL), SMG captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (13.5% vs. -15.7% operating margin) and revenue trajectory (-21.8% vs. -80.5% YoY).
Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile SMG trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FMC vs SMG. Trailing 12-month operating profitability (FMC -15.7% vs SMG 13.5%) and valuation multiples (FMC 5.5x vs SMG 13.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Agricultural Inputs value chain with $3.7B market capitalization and 13.5% operating margin.
OpEx & R&D Reinvestment18.9% of Rev ($1.15B)
90D Engineering Disclosures0 Published
Investor FAQ FMC vs SMG Key Questions & Quantitative Answers
As of Nov 17, 2026, The Scotts Miracle-Gro Company (SMG) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). FMC carries a Unified Composite Score of 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin), whereas SMG carries 39.4/100 (SELL) at $62.79 (13.5x Forward P/E, 13.5% operating margin). Composite vs. Pillar Nuance: While FMC currently prints a higher short-term Unified Composite Score (46.7/100 HOLD vs. SMG 39.4/100 SELL), SMG captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (13.5% vs. -15.7% operating margin) and revenue trajectory (-21.8% vs. -80.5% YoY). Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile SMG trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SMG leads the Growth & Scale pillar: FMC posts -80.5% YoY revenue growth and -77.6% YoY earnings growth on $2.81B TTM revenue (17.6% gross margin, -15.7% operating margin), compared with SMG at -21.8% YoY revenue growth and -25.5% YoY earnings growth on $6.08B TTM revenue (32.4% gross margin, 13.5% operating margin). On trailing 12-month operating scale, FMC generates $2.81B in USD-normalized revenue versus $6.08B for SMG. In operating R&D and SG&A reinvestment, FMC deploys 33.3% of Rev ($937M) (0 90-day corporate R&D disclosures) versus 18.9% of Rev ($1.15B) (0 disclosures) for SMG.
FMC screens cheaper on headline valuation multiples. FMC trades at 5.5x Forward P/E, 4.2x Trailing P/E, 0.46x PEG, and 1.5x EV/Revenue (10.5% FCF margin), whereas SMG trades at 13.5x Forward P/E, 19.4x Trailing P/E, 3.62x PEG, and 0.6x EV/Revenue (15.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FMC (-218.9% ROE) versus SMG (-47.6% ROE) capital efficiency.
In options market volatility and institutional positioning, FMC carries 104.3% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.82x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.21β · 132% Vol realized risk). By comparison, SMG carries 32.4% implied volatility (73rd %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.73β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.